Quarterly Results

ASPIRA PATHLAB & DIAGNOSTICS LTD.

NSE : NABSE : 540788ISIN CODE : INE500C01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE78.133.72 (+5 %)
PREV CLOSE ( ) 74.41
OPEN PRICE ( ) 77.94
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9911
TODAY'S LOW / HIGH ( )76.64 78.13
52 WK LOW / HIGH ( ) 2579.7
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Sep 2024
Jun 2024
Jun 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
61.78
46.37
26.04
Total Expenditure
48.21
42.87
29.3
PBIDT (Excl OI)
13.57
3.5
-3.26
Other Income
0.76
0.92
1
Operating Profit
14.32
4.41
-2.26
Interest
0.79
0.81
0.98
Exceptional Items
NA
NA
NA
PBDT
13.53
3.60
-3.24
Depreciation
3.64
3.77
3.92
Profit Before Tax
9.89
-0.16
-7.16
Tax
NA
NA
NA
Provisions and contingencies
NA
NA
NA
Profit After Tax
9.89
-0.16
-7.16
Extraordinary Items
NA
NA
NA
Prior Period Expenses
NA
NA
NA
Other Adjustments
NA
NA
NA
Net Profit
9.89
-0.16
-7.16
Minority Interest
NA
NA
NA
Shares of Associates
0.64
Other related items
Misc. Expenses Written off
NA
NA
NA
Consolidated Net Profit
9.9
0.47
-7.16
Equity Capital
102.93
102.93
102.93
Face Value (IN RS)
10
10
10
Reserves
NA
NA
NA
Calculated EPS
0.96
0.04
-0.69
Calculated EPS (Annualised)
3.84
0.18
-2.78
No of Public Share Holdings
8384036
8366036
8299627
% of Public Share Holdings
81.45
81.28
80.63
 
NA
NA
NA
PBIDTM% (Excl OI)
21.96
7.54
-12.51
PBIDTM%
23.17
9.53
-8.67
PBDTM%
21.90
7.78
-12.44
PBTM%
16.00
-0.34
-27.49
PATM%
16.00
-0.34
-27.49
 
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.